SO-007Regorafenib plus nivolumab in patients with advanced colorectal or gastric cancer: an open-label, dose-finding, and dose-expansion phase 1b trial (REGONIVO, EPOC1603). (2nd July 2019) - Hara, H; Fukuoka, S; Takahashi, N; Kojima, T; Kawazoe, A; Asayama, M; Yoshii, T; Kotani, D; Tamura, H; Mikamoto, Y; Sugama, A; Wakabayashi, M; et al.